bullish
KLBF: Medicine Maker Cashed up on Product Strategy
223 Views28 Sep 2016 13:37
Share price is less volatile, good growth in core profit, and slow asset growth relative to its sector
KLBF’s focus to compete with promotional...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 11-minute read)
Discussions
(Paid Plans Only)
A. Stotz Investment Research
Quantamental Investing to beat Benchmarks
Price Chart(Sign Up to Access)
x